Académique Documents
Professionnel Documents
Culture Documents
Inpatient
Agriculture
Outpatient
=
(
)
:
(
)
(central venous catheters)
-
Outbreaks of Escherichia coli O157 in spinach and
lettuce in the US.
=
-
Emerging and re-emerging
infections
.
penicillin 3
penicillin (ampicillin)
.
1
,
.
(
).
.
.
=
Antibiotic Mechanism of Action
Linezolid
Daptomycin
Daptomycin
Linezolid
Daptomycin
(
)
Mechanisms Of Antibiotic Resistance
Decreased
Permeability
Alteration in
Target
Molecule
Cycle of Antibiotic
R
Resistance Acquisition:
Bacterial Selection Selection by Drug X
Under increasing
antibiotic selection
pressure:
1. Bacteria resistant to a Replication
particular drug are
selected and replicate
2. Different antibiotics
select different Selection by Drug Y
bacteria but can
select resistant
phenotypes to other
drugs as well Replication
3. This results in
multidrug-resistant
(MDR) organisms and
increases their total
Resistance to: Drug Z
number Drug X Drug Y
.
,
(
)
Microbiome and normal flora
Reasons for Antibiotic Overuse :
Conclusions from 8 Focus Groups
Patient Concerns Physician Concerns
Want clear explanation Patient expects
Green nasal discharge antibiotic
Need to return to work Diagnostic uncertainty
Time pressure
Antibiotic Prescription
E-test
Kirby-Bauer
Disk Diffusion
Agar dilution
Concept of Breakpoint to Determine
EXAMPLE: Susceptibility
Susceptibility
Antibiotic MIC Breakpoint Susceptibility
testing for a
single isolate of Ampicillin >16 8 Resistant
Pseudomonas Gentamicin 2 4 Susceptible
aeruginosa
Cephalothin >16 N/A Resistant
Cefepime 8 32 Susceptible
Cefotaxime 16 16/32 Intermediate
-Breakpoint for Ceftazidime 2 32 Susceptible
intermediate resistance
for meropenem is 4 and Aztreonam 4 16 Susceptible
for
Ciprofloxacin 2 2 Resistant
piperacillin/tazobactam
(pip/tazo) 32 Amp/Sulbactam >16 8 Resistant
-Pip/tazo is the better Meropenem 4 4/8 Intermediate
choice between the two
-Ciprofloxacin is a poor
Pip/tazo 8 32-64/128 Susceptible
choice even though the
MIC is lowest of the three
Increase in MRSA Prevalence in US
Comparison to Other Drug-Resistant Organisms
MSSA MRSA
Unadjusted (N=165) (N=121) P Value
*Adjusted for other predictors of mortality: age, physical status, duration of surgery.
Engemann JJ, et al. Clin Infect Dis. 2003;36:592-598.
Decreased Susceptibility of S. pneumoniae to
Fluoroquinolones (FQRSP) in Canada
Relationship of Resistance to Antibiotic Use
5 15 - 64 y.o
6
Susceptibility to Fluoroquinolones (%)
3.5 4
3
2.5 3
2
1.5 2
1 1
0.5
0 0
1988 1989 1990 1991 1992 1993 1994 1995 1996 1997 1998